Bioxytran BIXT
OTC BIXT
$0.02 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Bioxytran (BIXT) Total Non-Current Liabilities (2010 - 2024)

Updated

Bioxytran (BIXT) recorded Total Non-Current Liabilities of $1.74 million in Q4 2024.

Analysis

Bioxytran (BIXT) Total Non-Current Liabilities (2010 - 2024) Analysis & Trends

Starting with Q4 2010, Bioxytran's Total Non-Current Liabilities history includes 6 quarters.

  • The Q4 2024 figure is the highest quarterly Total Non-Current Liabilities since Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,155.80 Bn 1,124.39 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 630.65 Bn 549.18 Bn 17.26 Bn 105.50 Bn
3 AbbVie 502.74 Bn 475.85 Bn 12.70 Bn 106.45 Bn
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 301.36 Bn 265.35 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn 33.91 Bn
7 Amgen 239.16 Bn 194.55 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 192.63 Bn 166.82 Bn 6.22 Bn 35.10 Bn
9 Pfizer 171.82 Bn 118.47 Bn 10.94 Bn 97.04 Bn
10 Bioxytran 2.29 Mn 1.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1.74 Mn
Mar 31, 2022 4.89 Mn
Dec 31, 2011 52,812.00
Sep 30, 2011 94,635.00
Jun 30, 2011 172,636.00
Dec 31, 2010 134,617.00
API Access

Bioxytran Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BIXT&period=max&api_key=YOUR_API_KEY